Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2015-03-09 Declaration of Voting R…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Declaration of the nb of shares and voting rights Feb.15
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is explicitly titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and references Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the 'Total number of shares' and the 'Total number of voting rights' as of a specific date (February 28, 2015). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2015-03-09 English
Déclaration actions et droits de vote au 31 Janvier 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights) and explicitly references Article 223-16 of the AMF General Regulation (Autorité des Marchés Financiers). It provides a table detailing the total number of shares and the total gross and net voting rights as of a specific date (January 31, 2015). This content directly relates to the official declaration of voting rights and capital structure updates, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2015-02-05 French
Declaration of the nb of shares and voting rights as January15
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references compliance with Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the total number of shares and the corresponding gross and net total voting rights as of a specific date (January 31, 2015). This content directly relates to the official declaration of voting rights and share capital structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2015-02-05 English
Virbac : Sustained growth in the fourth quarter
Earnings Release Classification · 99% confidence The document provides consolidated revenue figures for the fourth quarter (Q4) and the full year (2014) of the company Virbac. It details growth rates, organic growth, and segment performance (companion animals vs. food producing animals). The presence of detailed quarterly and annual financial tables, along with the date 'January 15, 2015' (typical for Q4/Year-end reporting), strongly indicates this is a release of periodic financial results. Since it is an initial announcement of key figures and highlights, it fits the definition of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) or a detailed Interim Report (IR) for a shorter period, nor is it a transcript (CT) or a management discussion (MDA). It is the initial release of the results. Q4 2014
2015-01-15 English
Virbac : poursuite d'une croissance soutenue au 4ème trimestre
Earnings Release Classification · 99% confidence The document is a press release dated January 15, 2015, detailing the company's financial performance for the fourth quarter and the full year 2014. It provides key figures for revenue (chiffre d'affaires) and growth rates, contrasting actual results with constant currency and constant perimeter results. This format, focusing on preliminary or summarized period results announced outside of a formal annual report (10-K) or comprehensive interim report (IR), strongly aligns with an Earnings Release (ER). The document is short (under 5,000 characters) and presents highlights rather than the full, audited financial statements found in a 10-K or IR. Q4 2014
2015-01-15 French
Virbac : bilan semestriel contrat de liquidité au 31 décembre 2014
Net Asset Value Classification · 95% confidence The document is titled "BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of means allocated to the liquidity contract) and reports the status of a liquidity contract (market making agreement) as of December 31, 2014, comparing it to the previous period (June 30, 2014). This type of regular update concerning market liquidity provision, often required by regulators, does not fit perfectly into the main financial reports (10-K, IR) or specific announcements (DIV, ER). It is a specific financial/regulatory update related to market operations. Given the options, it is closest to a specialized financial report or update. Since it is a specific, periodic report on a financial mechanism (liquidity contract balance), and not a general regulatory filing (RNS) or a standard financial report (IR/10-K), it is best classified under a specific financial category. However, none of the categories perfectly match 'Liquidity Contract Balance Sheet'. Given the context of financial reporting, and that it is a periodic statement on financial instruments/cash, it is most analogous to a specialized financial disclosure. Since it is a periodic statement detailing holdings related to market stability, and not a standard earnings report or audit, 'NAV' (Net Asset Value) is sometimes used for periodic fund/asset updates, but this is a liquidity contract. The most appropriate fallback for a specific, non-standard periodic financial disclosure that isn't a full report is often 'RNS' (Regulatory Filings) or, if it's considered a specialized financial statement, it might be grouped with other periodic updates. Given the nature of reporting on market-making activities, which is a specific financial arrangement, and lacking a better fit, I will classify it as a specialized financial report update. Since it is a periodic statement detailing assets/cash related to a specific financial arrangement, and it is not a standard earnings release or interim report, I will use 'RNS' as the most appropriate general regulatory/specialized filing category, as it is a required periodic disclosure related to market operations.
2015-01-09 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.